Cargando…
Preferential killing of melanoma cells by a p16-related peptide
We report the identification of a synthetic, cell-penetrating peptide able to kill human melanoma cells efficiently and selectively, while being less toxic to normal human melanocytes and nontoxic to human fibroblasts. The peptide is based on the target-binding site of the melanoma suppressor and se...
Autores principales: | Soo, Julia K., Castle, Joanna T., Bennett, Dorothy C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445694/ https://www.ncbi.nlm.nih.gov/pubmed/37522264 http://dx.doi.org/10.1242/bio.059965 |
Ejemplares similares
-
Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells
por: Song, Chang W., et al.
Publicado: (2012) -
Preferential killing of multidrug-resistant KB cells by inhibitors of glucosylceramide synthase
por: Nicholson, K M, et al.
Publicado: (1999) -
Selected drugs that inhibit DNA methylation can preferentially kill p53 deficient cells
por: Yi, Lan, et al.
Publicado: (2014) -
Influence of anaesthetics on tumour-cell kill and repopulation in B16 melanoma treated with melphalan.
por: Peacock, J. H., et al.
Publicado: (1978) -
Antibiotic in myrrh from Commiphora molmol preferentially kills nongrowing bacteria
por: Bhattacharjee, Mrinal K, et al.
Publicado: (2020)